Title |
Understanding the Cost-Effectiveness of Influenza Vaccination in Children: Methodological Choices and Seasonal Variability
|
---|---|
Published in |
PharmacoEconomics, May 2013
|
DOI | 10.1007/s40273-013-0060-7 |
Pubmed ID | |
Authors |
Anthony T. Newall, Juan Pablo Dehollain, Prudence Creighton, Philippe Beutels, James G. Wood |
Abstract |
The universal vaccination of children for influenza has recently been recommended in the UK and is being considered in other developed countries. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Practitioners (doctors, other healthcare professionals) | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 60 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 2% |
Unknown | 59 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 14 | 23% |
Researcher | 11 | 18% |
Student > Ph. D. Student | 7 | 12% |
Student > Postgraduate | 4 | 7% |
Other | 4 | 7% |
Other | 8 | 13% |
Unknown | 12 | 20% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 17 | 28% |
Nursing and Health Professions | 5 | 8% |
Social Sciences | 4 | 7% |
Agricultural and Biological Sciences | 4 | 7% |
Economics, Econometrics and Finance | 4 | 7% |
Other | 9 | 15% |
Unknown | 17 | 28% |
Attention Score in Context
This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 November 2021.
All research outputs
#5,000,657
of 24,520,187 outputs
Outputs from PharmacoEconomics
#519
of 1,959 outputs
Outputs of similar age
#39,850
of 196,402 outputs
Outputs of similar age from PharmacoEconomics
#7
of 30 outputs
Altmetric has tracked 24,520,187 research outputs across all sources so far. Compared to these this one has done well and is in the 79th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,959 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.3. This one has gotten more attention than average, scoring higher than 72% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 196,402 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 79% of its contemporaries.
We're also able to compare this research output to 30 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 80% of its contemporaries.